发明名称 Differentiation of human embryonic stem cells
摘要 The present invention provides methods to promote the differentiation of pluripotent stem cells into insulin producing cells. In particular, the present invention provides a method to produce a population of cells, wherein greater than 80% of the cells in the population express markers characteristic of the definitive endoderm lineage.
申请公布号 US9506036(B2) 申请公布日期 2016.11.29
申请号 US201113211951 申请日期 2011.08.17
申请人 Janssen Biotech, Inc. 发明人 Fryer Benjamin
分类号 C12N5/071 主分类号 C12N5/071
代理机构 代理人 Gianneschi Lois A.
主权项 1. An in vitro culture comprising an isolated population of in vitro differentiated cells and a serum-free cell culture medium supplemented with L-alanyl-L-glutamine in which the concentration of glucose does not exceed 10.5 mM, wherein greater than 80% of the cells in the population are definitive endoderm cells and express CXCR4 and CD99, and wherein said population of cells is obtained by a step-wise differentiation process comprising: (i) seeding clusters of pluripotent stem cells in a serum-free medium supplemented with L-alanyl-L-glutamine, and glucose at a concentration that does not exceed 10.5 mM; (ii) culturing the pluripotent stem cells for about one day in a serum-free medium supplemented with L-alanyl-L-glutamine, about 100 ng/ml activin A, about 20 ng/ml of Wnt-3a, and glucose at a concentration that does not exceed 10.5 mM; followed by (iii) culturing the cells for about three days in a serum-free medium supplemented with L-alanyl-L-glutamine, about 100 ng/ml activin A, and glucose at a concentration that does not exceed 10.5 mM, whereby the culture does not require further purification or selection of the definitive endoderm cells.
地址 Horsham PA US